Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Stan Druckenmiller’s Long-Term Picks

Page 1 of 2

Billionaire Stan Druckenmiller‘s family office, disclosed an equity portfolio valued at some $1.02 billion as of the end of 2014, representing a significant growth of 25.1%. The equity portfolio is mainly invested in Consumer Discretionary (30.9%), Health Care (30.3%), and Financials (13.4%) stocks. Duquesne Capital’s last 13F filing showed that the fund raised its exposure towards consumer discretionary and industrials stocks, but Mr. Druckenmiller reduced his holdings in the energy and materials sector. Among 10 largest holdings from Duquesne Capital’s equity portfolio (which amass 55.35% of the total portfolio value), some companies represent long-term bets. Among these companies are Alcoa Inc (NYSE:AA), Illumina, Inc. (NASDAQ:ILMN) and Workday Inc (NYSE:WDAY).


In this article we will look into Mr. Druckenmiller’s long-term picks held throughout 2014. These companies are large-cap stocks, which is obvious to see why, since the majority of most popular stocks among the hedge funds that we track are represented by large-cap companies. However, mimicking the activity of these funds by investing in their large-cap picks is not the best strategy for retail investors, since our tests of a portfolio consisting of 50 most popular picks among hedge funds underperformed the market by 7.0 basis points per month between 1999 and 2012. On the other hand small-cap picks have a better chance of helping an investor to beat the market, since our small-cap strategy returned 132% since the end of August 2012 until March 2015.

At the end of 2014, Illumina, Inc. (NASDAQ:ILMN) represented the second-largest holding in terms of value. Duquesne Capital holds 410.100 shares of the company valued at $75.7 billion. The fund initiated a position with 506.700 shares during the third quarter of 2013. Meanwhile, the stock surged by 16.3% during the fourth quarter.

Illumina, Inc. (NASDAQ:ILMN) has posted results for its fourth-quarter of fiscal 2014, ended December 31, 2014. Revenue increased by 32.28% in the fourth quarter when compared to the same quarter one year prior. Further, the net income increased by 90.02% when compared to the same quarter one year before, to $153.28 million from $80.66 million. Along with this, earnings per share (EPS) have significantly increased in the fourth quarter of 2014 from the same quarter of fiscal 2013, to $1.03 from $0.56.

We must mention that the company has a diversified and attractive portfolio. Further, it focuses on new products, taking advantage in an era of technology advances, which constantly pushes down costs. In addition, strategic moves are part of management´s action. Illumina, Inc. (NASDAQ:ILMN) has formed a strategic alliance with Merck Serono, the biopharmaceuticals business of Germany’s Merck KGaA. For the upcoming future, we can expect a higher demand for the company´s products, which represents a long-term growth opportunity to continue its market leadership.

Several investors reported long positions in the company. Andreas Halvorsen and Samuel Isaly are two prominent investors in Illumina, Inc. (NASDAQ:ILMN), holding 8.29 million shares and 1.47 million shares respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!